FDA Long-Term Globalization Strategy To Include Increased Data Sharing
This article was originally published in The Rose Sheet
FDA looks to rely less on its own staff and more on data and resource sharing with other countries to manage the increasingly global food, drug, medical device and cosmetics industries, according to the agency's acting second-in-command.
You may also be interested in...
John Taylor, counselor to FDA Commissioner Margaret Hamburg, will serve temporarily as second-in-command while Hamburg considers how to reorganize the agency's leadership following Principal Deputy Commissioner Josh Sharfstein's departure.
In recent interview, CEO Blake Cadwell talked about Soundly’s business model and outlook for hearing aid marketplace after FDA's pending publication of rule aiming to make the devices more accessible. Firm since June has offered online testing and advice for customers about hearing aids best suited for their needs.
Establishing VMS products MPL as stated within legislation to re-authorize FDA user fee programs for drugs, biologics and medical device applications isn’t urgent enough to prevent passing user fee bill, says CRN chief Steve Mister.